RecruitingPhase 2NCT05815784

Myopia Control: a Comparison Study Between Atropine and MiSight

Myopia Control in the Pediatric Population: a Comparison of MiSight, Naturalvue Multifocal, and Atropine 0.05%

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Enrollment

348 participants

Start Date

May 2, 2023

Study Type

INTERVENTIONAL

Conditions

Myopia

Summary

This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.

Eligibility

Min Age: 5 YearsMax Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Atropine and a medical device called MiSight contact lenses for people with myopia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 5 Years to 12 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.